Screener / SEC EDGAR /CIK 0001356576 /10-K filed Mar 2, 2026, compared with Feb 25, 2025 /Numbers from the XBRL of the 10-Ks
Health care · Pharmaceuticals

Supernus, Inc. SUPN

Compare with peers Embed
Planned sales, announced before they happen

0 trading plans running, 11 Form 144 notices for $10.2M

10-Q, 10-K and Form 144

What SUPN's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Aug 27, 2023 to Nov 16, 2026. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Charles Newhall
Director
Ended 10b5-1 plan Aug 12, 2026 10-Q Oct 29, 2026
Jack Khattar
President, Chief Executive Officer and Director
Ended 10b5-1 plan Aug 12, 2026 10-Q Oct 29, 2026
William Todd Horich
Senior Vice President, Chief Commercial Officer
Ended 10b5-1 plan Aug 12, 2026 10-Q Oct 29, 2026
Charles Newhall
Director
Adopted 10b5-1 plan Jun 15, 2026 10-Q Aug 3, 2026
What the company wrote
Name and Title of Director or Officer Rule 10b5-1 Trading Arrangement (1) Trading Arrangement Adopted or Terminated Date of Adoption or Termination Duration of Trading Arrangement Aggregate Number of Securities to be Purchased Pursuant to Trading Arrangement Aggregate Number of Securities to be Sold Pursuant to Trading Arrangement Charles Newhall Director Yes Adopted June 15, 2026 First Transaction Date through June 15, 2027 — 5,000 ____________________________________ (1) Indicates whether the trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
William Todd Horich
Senior Vice President, Marketing & Market Access
Ended 10b5-1 plan Feb 5, 2026 10-Q May 5, 2026
What the company wrote
Name and Title of Director or Officer Rule 10b5-1 Trading Arrangement (1) Trading Arrangement Adopted or Terminated Date of Adoption or Termination Duration of Trading Arrangement Aggregate Number of Securities to be Purchased Pursuant to Trading Arrangement Aggregate Number of Securities to be Sold Pursuant to Trading Arrangement William Todd Horich Senior Vice President, Chief Commercial Officer Yes Adopted March 13, 2026 First Transaction Date through March 12, 2027 — 44,000 William Todd Horich Senior Vice President, Marketing & Market Access (2) Yes Terminated February 5, 2026 First Transaction Date through December 15, 2026 — 16,875 ____________________________________ (1) Indicates whether the trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). (2) Mr. Horich was appointed to Senior Vice President and Chief Commercial Officer in March 2026. The termination of his 10b5-1plan in February 2026 preceded his appointment to his current position
Padmanabh Bhatt
SVP, Chief Scientific Officer, Intellectual Property
Adopted 10b5-1 plan Dec 15, 2025 10-K Mar 2, 2026
Jack Khattar
President, Chief Executive Officer and Director
Adopted 10b5-1 plan Dec 12, 2025 10-K Mar 2, 2026
Frank Mottola
SVP, Chief Technology Operations Officer
Adopted 10b5-1 plan Sep 15, 2025 10-Q Nov 6, 2025
What the company wrote
The table below lists the insider trading arrangements adopted or terminated during the third quarter of 2025: Name and Title of Director or Officer Rule 10b5-1 Trading Arrangement (1) Trading Arrangement Adopted or Terminated Date of Adoption or Termination Duration of Trading Arrangement Aggregate Number of Securities to be Purchased Pursuant to Trading Arrangement Aggregate Number of Securities to be Sold Pursuant to Trading Arrangement Frank Mottola SVP, Chief Technology Operations Officer Yes Adopted September 15, 2025 January 14, 2026 — 20,000 ____________________________________ (1) Indicates whether the trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). (2) This trading arrangement covers the exercise and sale of stock options, with a portion of such sales limited to an amount reasonably estimated such that the net proceeds from the sale are sufficient to cover the exercise cost and taxes associated with the exercise of the stock options.
Bethany Sensenig
Adopted 10b5-1 plan May 15, 2025 10-Q Aug 5, 2025
What the company wrote
The table below lists the insider trading arrangements adopted or terminated during the second quarter of 2025: Name and Title of Director or Officer Rule 10b5-1 Trading Arrangement (1) Trading Arrangement Adopted or Terminated Date of Adoption or Termination Duration of Trading Arrangement Aggregate Number of Securities to be Purchased Pursuant to Trading Arrangement Aggregate Number of Securities to be Sold Pursuant to Trading Arrangement Bethany Sensenig Yes Adopted May 15, 2025 February 25, 2026 — 9,844 ____________________________________ (1) Indicates whether the trading arrangement is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). (2) This trading arrangement covers the exercise and sale of stock options, with a portion of such sales limited to an amount reasonably estimated such that the net proceeds from the sale are sufficient to cover the exercise cost and taxes associated with the exercise of the stock options.
Charles Newhall
Adopted 10b5-1 plan Mar 3, 2025 10-Q May 6, 2025
Jack Khattar
President, Chief Executive Officer and Director
Adopted 10b5-1 plan Nov 14, 2024 10-K Feb 25, 2025
Padmanabh Bhatt
SVP, Chief Scientific Officer, Intellectual Property
Adopted 10b5-1 plan Sep 3, 2024 10-Q Nov 4, 2024
Jack Khattar
President, Chief Executive Officer and Director
Ended 10b5-1 plan Aug 12, 2024 10-Q Nov 4, 2024
Padmanabh P. Bhatt, Ph.D
Senior Vice President of Intellectual Property and Chief Scientific Officer
Adopted 10b5-1 plan Sep 7, 2023 10-Q Nov 8, 2023
Jack Khattar
President, Chief Executive Officer and Director
Adopted 10b5-1 plan Aug 27, 2023 10-Q Nov 8, 2023
Jack Khattar
President, Chief Executive Officer and Director
Adopted other arrangement May 19, 2023 10-Q Aug 8, 2023
Show the other 8 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 9, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Mar 17, 2026 PADMANABH P BHATT
Officer
57,250 $2.9M
Mar 16, 2026 PADMANABH P BHATT
Officer
50,000 $2.5M
Mar 13, 2026 THE KBT TRUST U/A DTD 12/30/2010
Director, Officer
35,000 $1.8M
Mar 12, 2026 FREDERICK M HUDSON
Director
5,369 $272K
Mar 10, 2026 WILLIAM TODD HORICH
Officer
4,439 $244K
Mar 9, 2026 WILLIAM TODD HORICH
Officer
4,438 $240K
Mar 9, 2026 FRANK MOTTOLA
Officer
1,623 $87K
Mar 6, 2026 GEORGES GEMAYEL
Director
8,787 $466K
Mar 5, 2026 GEORGES GEMAYEL
Director
10,000 $537K
Feb 19, 2026 BETHANY SENSENIG
Director
4,475 $225K
Dec 19, 2025 FRANK MOTTOLA
Officer
20,000 $986K
Show the other 3 notices

From the Form 144 XML filed with the SEC, since Dec 19, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/SUPN/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.